Metraipolis › archive › dc_4e66174cb10e

CD4+T cell metabolic reprogramming as therapeutic targets in neurodegenerative diseases — Europe PMC PMID:41742223

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41742223
DOI: 10.1186/s13041-[numero omesso]-6
License (as archived): solo-consultazione
Archived: 2026-11-05T08:08:33.780Z
SHA-256 of the archived text: fa89040e2f65bcb13612ed6614fc28c710a47a2ecd448d73f27ba8319e930c36
Stable URL of this page: https://metraipolis.com/documento/dc_4e66174cb10e

How to cite

CD4+T cell metabolic reprogramming as therapeutic targets in neurodegenerative diseases — Europe PMC PMID:41742223 — Europe PMC (en), https://europepmc.org/article/MED/41742223 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e66174cb10e (Metraipolis archive dc_4e66174cb10e, sha256 fa89040e2f65bcb13612ed6614fc28c710a47a2ecd448d73f27ba8319e930c36)

BibTeX

@misc{dc4e66174cb10e,
  title = {CD4+T cell metabolic reprogramming as therapeutic targets in neurodegenerative diseases — Europe PMC PMID:41742223},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41742223},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e66174cb10e; sha256 fa89040e2f65bcb13612ed6614fc28c710a47a2ecd448d73f27ba8319e930c36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41742223. Agents can read the archived copy with the MCP tool read_document.